Cent, a Bengaluru company that offers preventive health checks combining full-body imaging and blood tests, has raised a $15m (about ₹143 crore) Series A co-led by Blume Ventures and existing investor South Park Commons. It announced the round on 27 October 2026.
Individual investors Arun Sarin, a former chief executive of Vodafone, Srinivas Narayanan, OpenAI's former B2B chief technology officer, Sharath Narayana, Aprameya Radhakrishna and Krishan Sridhar also joined. Entrepreneur India reported that the round combines equity and debt; the split and the valuation were not disclosed.
Alongside the raise, Cent said it had acquired Medsee, an AI radiology reporting platform founded by Chitra Singh. Terms were not disclosed.
“India's healthcare system is still built to treat illness, not to find it early. We believe the next shift is preventive care that is precise and accessible at scale,”Anshul Khandelwal, co-founder, Cent
What Cent does
Cent's main product, the Cent Check, brings together a full-body MRI, low-dose CT, a DEXA bone scan, ECG, echocardiogram and more than 100 blood biomarkers in a visit of about two hours. Results are combined under its own protocol, which looks at cancer, cardiac, neurological and metabolic risk, and reviewed by specialists. Members then get a doctor-led health plan and follow-up through the year.
Inc42 reported that the package is priced at ₹27,500 and that AI is used to merge findings across tests and to shorten MRI scan times. Medsee's software drafts structured radiology reports for radiologists to review, which Cent says will help it keep reporting fast and consistent as volumes grow.
The company first ran its protocol through partner labs and then opened its own centres in Bengaluru, Mumbai and Delhi NCR.
What 10,000 scans showed
Cent says it has completed 10,000 scans. In a blog post published with the funding news, the founders said one in four members who felt well had a finding worth acting on, and one in 40 needed immediate medical attention. Those findings included early-stage tumours, badly narrowed arteries and aneurysms. These figures are the company's own and have not been independently reviewed.
The founders argue that India's health system is built to treat illness rather than find it early, and that routine check-ups based on blood tests miss disease growing in the organs. They cite estimates that seven in ten cancers in India are found at stage three or four.
Founders and plans
Cent was founded in 2025 by Shashank ND, co-founder of the health platform Practo, Anshul Khandelwal, the former chief marketing officer of Ola Electric, and Arpit Garg, former product head at Lenskart. Inc42 reported that it raised a $5m seed round earlier in 2026 from OneFlow Holdings and South Park Commons.
The new money will go into research and development and into hiring for its AI, engineering and clinical teams. Cent aims to reach 10 million scans by 2035 and plans to use its scan data to set health benchmarks for Indians without symptoms, train models that spot disease risk earlier and support clinical research.
Company website: cent.health